You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent adult non-Hodgkin lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

Not yet recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • (no location specified)
Aug 4, 2023

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

Completed
  • Grade 3a Follicular Lymphoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Non-Hodgkin Lymphoma
    • San Antonio, Texas
      NEXT Oncology
    Jan 6, 2023

    Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

    Not yet recruiting
    • Follicular Lymphoma
    • Low Grade Non-Hodgkin's Lymphoma, Adult
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

    Not yet recruiting
    • Mature B-Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 6, 2022

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    B-cell Non-Hodgkin's Lymphoma Trial (SHR-A1912; R-Chemo)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • SHR-A1912; R-Chemo
    • (no location specified)
    Oct 23, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2023

    Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

    Not yet recruiting
    • Relapsed/Refractory Non-Hodgkin Lymphoma
    • Duarte, California
    • +1 more
    Oct 13, 2023

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

    Active, not recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • New York, New York
    • +2 more
    Oct 12, 2023

    Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • CD38-SADA:177Lu-DOTA Complex
    • (no location specified)
    Aug 15, 2023

    Non-hodgkin Lymphoma Trial in Tianjin (GNC-038)

    Recruiting
    • Non-hodgkin Lymphoma
    • Hefei, Anhui, China
    • +9 more
    Jan 12, 2023

    Quality of Life in Adult and Pediatric Nodular

    Recruiting
    • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
      • Aurora, Colorado
      • +1 more
      Oct 27, 2023

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +20 more
      • Chimeric Antigen Receptor T-Cell Therapy
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 11, 2022

      B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

      Recruiting
      • B Cell Non-Hodgkin's Lymphoma
      • CD19/CD20-directed CAR-T cells
      • Duarte, California
        City of Hope Medical Center
      Aug 10, 2022